These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12786846)

  • 1. Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment.
    Tjiu JW; Hsiao CH; Tsai TF
    Br J Dermatol; 2003 May; 148(5):1060-1. PubMed ID: 12786846
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermatoscopic findings in cutaneous Rosai-Dorfman disease and response to low-dose thalidomide.
    Wang F; Zhou H; Luo DQ; Han JD; Chen MK
    J Dtsch Dermatol Ges; 2014 Apr; 12(4):350-2. PubMed ID: 24580965
    [No Abstract]   [Full Text] [Related]  

  • 3. Facial Cutaneous Rosai-Dorfman Disease.
    Flores-Terry MÁ; Romero-Aguilera G; González-López L; García-Arpa M
    Actas Dermosifiliogr; 2017 Jun; 108(5):480-482. PubMed ID: 28109522
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic challenge of dapsone in the treatment of purely cutaneous Rosai-Dorfman disease.
    Chang HS; Son SJ; Cho KH; Lee JH
    Clin Exp Dermatol; 2011 Jun; 36(4):420-2. PubMed ID: 21564180
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide.
    Li X; Hong Y; An Q; Chen J; Wei H; Chen HD; Gao XH
    JAMA Dermatol; 2013 Aug; 149(8):992-3. PubMed ID: 23783880
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous Rosai-Dorfman disease of the face with a leonine appearance: successful response to dapsone.
    Lee YI; Kim SK; Oh SH; Kim DY
    Eur J Dermatol; 2018 Apr; 28(2):255-256. PubMed ID: 29400286
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate.
    Sun NZ; Galvin J; Cooper KD
    JAMA Dermatol; 2014 Jul; 150(7):787-8. PubMed ID: 24789266
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide.
    Nadal M; Kervarrec T; Machet MC; Petrella T; Machet L
    Acta Derm Venereol; 2015 Jul; 95(6):758-9. PubMed ID: 25632986
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical Primary Cutaneous Rosai Dorfman Disease: A Case Report.
    Kinio AE; Sawchuk MA; Pratt M
    J Cutan Med Surg; 2017; 21(5):460-463. PubMed ID: 28639453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dense Papules on the Face: A Quiz.
    Zhou H; Zhao Q; Zhao L; Shang Q; Li J; Geng S
    Acta Derm Venereol; 2019 Sep; 99(10):935-936. PubMed ID: 30938828
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous Rosai-Dorfman disease.
    Ohnishi A; Yoshida Y; Yamamoto O
    J Dermatol; 2008 Sep; 35(9):604-5. PubMed ID: 18837709
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosai-Dorfman disease: three difficult-to-diagnose cases.
    Du J; Ding X; Cai L; Sun P; Zhou C; Zhang J
    Eur J Dermatol; 2010; 20(5):650-1. PubMed ID: 20621850
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case.
    Frater JL; Maddox JS; Obadiah JM; Hurley MY
    J Cutan Med Surg; 2006; 10(6):281-90. PubMed ID: 17241598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans cells histiocytosis with vulvar involvement and responding to thalidomide therapy--case report.
    Fernandes LB; Guerra JG; Costa MB; Paiva IG; Duran FP; Jacó DN
    An Bras Dermatol; 2011; 86(4 Suppl 1):S78-81. PubMed ID: 22068778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual case of multiple cutaneous Rosai-Dorfman disease involving two separate parts of the body.
    Jia J; Tian Q; Zhang H; Zheng Y
    Int J Dermatol; 2017 May; 56(5):576-578. PubMed ID: 28255989
    [No Abstract]   [Full Text] [Related]  

  • 16. Coexistence of localized Langerhans cell histiocytosis and cutaneous Rosai-Dorfman disease.
    Wang KH; Cheng CJ; Hu CH; Lee WR
    Br J Dermatol; 2002 Oct; 147(4):770-4. PubMed ID: 12366428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sinus histiocytosis with massive lymphadenopathy: FDG-PET/CT documented partial remission after treatment with 2-chlorodeoxyadenosine].
    Adam Z; Mašlaň J; Křen L; Kodet R; Koukalová R; Řehák Z; Červinek L; Pour L; Krejčí M; Sandecká V; Král Z; Mayer J
    Vnitr Lek; 2016; 62(6):491-9. PubMed ID: 27485849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease.
    Hoyo-Muñoz A; Collado-Borrell R; Escudero-Vilaplana V; Bastos-Oreiro M; Herranz-Alonso A; Sanjurjo-Sáez M
    J Clin Pharm Ther; 2022 Apr; 47(4):548-551. PubMed ID: 34514634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image Gallery: Metachronic occurrence of primary cutaneous marginal zone B-cell lymphoma and primary cutaneous Rosai-Dorfman disease in the same patient.
    González-Quesada A; Bastida J; Rivero-Vera JC; Piris-Pinilla MA; Limeres-González MA
    Br J Dermatol; 2017 Dec; 177(6):e355. PubMed ID: 29313941
    [No Abstract]   [Full Text] [Related]  

  • 20. Thalidomide as a potential treatment for scleromyxedema.
    Caradonna S; Jacobe H
    Arch Dermatol; 2004 Mar; 140(3):277-80. PubMed ID: 15023770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.